Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. - Wikidata - awgldk - TriplyDB

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

http://www.wikidata.org/entity/Q50859911

about

Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future Cutaneous immunization: an evolving paradigm in influenza vaccines Improving seasonal and pandemic influenza vaccines Microneedle-based vaccines Microneedle and mucosal delivery of influenza vaccines.Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.Infusion pressure and pain during microneedle injection into skin of human subjects.An electrically active microneedle array for electroporation.Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.Hepatitis B vaccine by intradermal route in non responder patients: an update.Laser vaccine adjuvant for cutaneous immunization.Micro-fractional epidermal powder delivery for improved skin vaccination Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.Rapid intradermal delivery of liquid formulations using a hollow microstructured array Hollow microneedles for intradermal injection fabricated by sacrificial micromolding and selective electrodeposition.High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.Intradermal delivery of vaccines: potential benefits and current challenges.An update on the use of laser technology in skin vaccination.Enabling skin vaccination using new delivery technologies.Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.Delivery systems for intradermal vaccination Rapid local anesthesia in humans using minimally invasive microneedles.Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.Microneedles for drug and vaccine delivery Stability of influenza vaccine coated onto microneedles.Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults.Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine

P2860

Q26778469-E4F1DF06-89D1-47C0-BC32-647F4DC202FA Q27330580-45ED62C3-46CE-4780-897F-DAF1C2C5F84C Q27486899-1E45AC83-6CFE-43D3-9DBF-E60E9C89AA2F Q28087074-DFD5D064-17F5-431A-B0B7-11F99962E5CF Q30358895-F8BBF37F-1D03-45DD-A9C6-41FA3AAADC75 Q30377211-D55421DF-1B8F-4ED9-9C5E-A54D410366BA Q30380910-AE3D2502-3A36-4E5C-8BDE-D4FDABC91BA2 Q30418015-F91F352D-6570-4355-8420-EBE931120CA8 Q30423733-00D57F0F-7809-4009-93D3-D8C0072224E1 Q30462818-64EBB85D-0DDF-4255-88CF-9C2E5CEF2FFA Q33518647-F900DEF2-35E1-46CB-A8D9-BD107015920D Q33557050-A50644F0-F285-424E-BC13-4CB6178B1887 Q33578064-9DF15703-69B2-4ED9-BBC5-9E381E84A79D Q33588044-7321C937-1982-4C78-B2B6-6028181321C6 Q33603206-334975A0-67CA-4E05-B54A-29E54DB30D5F Q33664783-468E4136-0160-434C-A6BF-E49CEDEB14C9 Q33682225-A36FE2F6-0B3B-4F27-9346-C3A4AB3A34F8 Q34005731-EE2B356B-758B-4209-BBB7-228129BD0C50 Q34036643-1F0B8752-8A23-4B7E-96C9-F25E0D04BBDA Q34046148-78ED6B2B-8722-48FD-8E5B-ED49E2C4A20B Q34229340-0C32AD77-8610-4DC4-86F2-5083747EEF2B Q34288194-D22B14FE-2180-4039-B0A4-DA385F8CCA6C Q34414561-39EC01FB-DE56-4DCE-9980-727F5D4A6A68 Q34439999-7BE05147-1DF2-4A5C-97A8-9F930B716535 Q34466125-1FABDB80-9D33-4006-B3A2-0DE3DE9EF67B Q34601669-90CE0349-860E-4FFE-92A1-37C9ECDE608A Q35017651-982FB926-4991-4AE7-B42B-41F969D69D17 Q35126354-531E1854-8AA9-44F0-AF3C-B5D6DF7B69CD Q35148060-58DCF5A2-696B-4B22-824C-7DE54AED8090 Q35214379-8838D6D3-3D80-4648-B24E-932B2541E05B Q35435168-B663BE04-1CA7-4343-87E1-85E79F18584C Q35886486-E6731ED8-3FC8-42DC-BBFC-37E54BA438FB Q35929406-BBB2EDF3-54D4-49D5-9E32-A6B0C415269D Q35952784-9B982A3F-F652-4B48-8910-EE35B3DD3E6B Q36164749-DE6A10CA-4A02-4FAF-B633-23A3326077BA Q36650284-1893B8D5-3432-48BA-8E6C-1D3A23561457 Q36887912-AAD5140C-6122-4898-9504-3F00528514EC Q37159662-A501A378-7C37-4209-934D-E3F3559ED104 Q37177201-A7583C3B-370E-4A85-B513-3E1F02AA0EE9 Q37190877-186490CE-D638-4DB7-844B-430DE1D95301

P2860

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

http://www.wikidata.org/entity/Q50859911

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Evaluation of the clinical per ...... nd associated delivery system.

@en

Evaluation of the clinical per ...... nd associated delivery system.

@nl

type

label

Evaluation of the clinical per ...... nd associated delivery system.

@en

Evaluation of the clinical per ...... nd associated delivery system.

@nl

prefLabel

Evaluation of the clinical per ...... nd associated delivery system.

@en

Evaluation of the clinical per ...... nd associated delivery system.

@nl

P1433

Q50859911-3F1C9268-F36D-4F69-A15E-7932CD8FBD24

P1476

Q50859911-81C2EC17-6D4E-4D8B-AD9E-4183CB33595E

P2093

Q50859911-386AE14B-F954-42AE-94AA-D781A9330F11

Q50859911-4759EEC4-5B30-4FCD-941E-3B18572E8EBF

Q50859911-5214B25A-4E55-4186-B148-7B6689D5A5B2

Q50859911-639B4666-CE98-473C-8F26-1517C448D975

Q50859911-74A5C444-0127-4C66-97E2-687F4F3ECF6B

Q50859911-7FA8893A-D1AD-4387-B7C2-824459DCFD01

Q50859911-E64BFB80-DE7F-47E1-90B1-1EA3930E8BFC

P304

Q50859911-0B691E64-8FA8-43CA-A11C-D490A29CB662

P31

Q50859911-0F987544-E5AD-4E60-A34E-D0D18B30AB28

P356

Q50859911-56630D3A-4F2C-4945-B55E-E2CC3362C2F9

P407

Q50859911-29E3BCFB-343D-4BF1-B1AE-32DE779B0C77

P433

Q50859911-B2F4EDB0-1DB2-49BD-9AA1-8C5A623B7E84

P478

Q50859911-CBE5455B-68EC-43CF-8F58-323BA7FE2D14

P577

Q50859911-2616E3C5-3687-4079-B0A6-D02956E9636B

P5875

Q50859911-C15C8BBD-65F6-4896-8F7A-31D352F8604A

P698

Q50859911-CADCAE06-D74A-4E46-A835-3613A1FC3BB7

P356

J.VACCINE.2007.10.020

P1433

P1476

Evaluation of the clinical per ...... nd associated delivery system.

@en

P2093

John A Mikszta

http://www.w3.org/2001/XMLSchema#string

Noel G Harvey

http://www.w3.org/2001/XMLSchema#string

Paul Alchas

http://www.w3.org/2001/XMLSchema#string

Paulina Regolini

http://www.w3.org/2001/XMLSchema#string

Philippe E Laurent

http://www.w3.org/2001/XMLSchema#string

Ronald Pettis

http://www.w3.org/2001/XMLSchema#string

Stephane Bonnet

http://www.w3.org/2001/XMLSchema#string

P304

8833-8842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2007.10.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5823115

http://www.w3.org/2001/XMLSchema#string

P698

18023942

http://www.w3.org/2001/XMLSchema#string